Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998788809> ?p ?o ?g. }
- W1998788809 endingPage "542" @default.
- W1998788809 startingPage "535" @default.
- W1998788809 abstract "The BLA expression of eight Burkitt lymphoma lines was high, whereas it was negative in four, including the two IgG producers tested. Most lymphoblastoid cell lines (LCL) of normal origin had only a low percentage of positive cells, not significantly above background, although a few had up to 30% positives. EBV conversion of the EBV-negative Burkitt lymphoma line Ramos destabilized the high BLA expression, leading to a decrease in the average number of positive cells in the majority of the converted sublines in parallel with considerable fluctuation in antigen expression within each subline. Our group has previously shown that EBV-conversion of Ramos cells can induce certain differentiation steps (Spira et al., 1981 a). EBV-converted sublines of another EBV-negative Burkitt lymphoma, BJAB, showed a much greater stability previously and remained unchanged with regard to BLA expression in our present experiments. Eight T-cell leukemias, three myeloid leukemia lines and two diffuse histiocytic lymphomas were negative for BLA, whereas two myeloma lines were 30-40% positive. A histiocytic tumor had marginal reactions. Hybrids derived from the fusion of high with low BLA-reactive parental lines showed all three possible patterns (high, intermediate and low), provided that B-cell lines were fused with each other. Fusion of two Burkitt lymphoma lines with the K562 erythroleukemia line led to the extinction of BLA expression, as well as to the eclipse of other B-cell markers. B-lymphoma and leukemia (CLL) cells harvested directly from the patient showed a heterogeneous reactivity pattern. Strong to intermediate BLA expression was found among CLL cells and in most histological groups of B-CLL lymphomas except the centroblastic group (3/3 negatives). IgG-expressing follicular lymphomas were less reactive than IgM +/- IgD lymphomas of the same group. Immunocytomas were also low-reactive. BLA can be thus expressed on a variety of B-cell neoplasms; the degree of its expression appears to be related to the stage of differentiation." @default.
- W1998788809 created "2016-06-24" @default.
- W1998788809 creator A5008053131 @default.
- W1998788809 creator A5009344154 @default.
- W1998788809 creator A5038071947 @default.
- W1998788809 creator A5044244232 @default.
- W1998788809 creator A5051391047 @default.
- W1998788809 creator A5070718117 @default.
- W1998788809 date "1983-05-15" @default.
- W1998788809 modified "2023-10-03" @default.
- W1998788809 title "Expression of the bla antigen, defined by the monoclonal 38.13 antibody, on burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other b-cell lymphomas and leukemias" @default.
- W1998788809 cites W1500473631 @default.
- W1998788809 cites W1591208477 @default.
- W1998788809 cites W1803359669 @default.
- W1998788809 cites W1968028322 @default.
- W1998788809 cites W1969149509 @default.
- W1998788809 cites W1979751191 @default.
- W1998788809 cites W1982731253 @default.
- W1998788809 cites W1986923551 @default.
- W1998788809 cites W1998980306 @default.
- W1998788809 cites W2000729067 @default.
- W1998788809 cites W2006416369 @default.
- W1998788809 cites W2013556409 @default.
- W1998788809 cites W2016819133 @default.
- W1998788809 cites W2022174826 @default.
- W1998788809 cites W2025646176 @default.
- W1998788809 cites W2031602286 @default.
- W1998788809 cites W2037082529 @default.
- W1998788809 cites W2051985758 @default.
- W1998788809 cites W2052687631 @default.
- W1998788809 cites W2059837496 @default.
- W1998788809 cites W2065627926 @default.
- W1998788809 cites W2069662977 @default.
- W1998788809 cites W2075402243 @default.
- W1998788809 cites W2087071278 @default.
- W1998788809 cites W2089218050 @default.
- W1998788809 cites W2127958409 @default.
- W1998788809 cites W2128663983 @default.
- W1998788809 cites W2133764756 @default.
- W1998788809 cites W2144358908 @default.
- W1998788809 cites W2171690205 @default.
- W1998788809 cites W2320954544 @default.
- W1998788809 cites W2506085008 @default.
- W1998788809 cites W4239139991 @default.
- W1998788809 cites W99326265 @default.
- W1998788809 doi "https://doi.org/10.1002/ijc.2910310503" @default.
- W1998788809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6303966" @default.
- W1998788809 hasPublicationYear "1983" @default.
- W1998788809 type Work @default.
- W1998788809 sameAs 1998788809 @default.
- W1998788809 citedByCount "39" @default.
- W1998788809 countsByYear W19987888092013 @default.
- W1998788809 countsByYear W19987888092014 @default.
- W1998788809 countsByYear W19987888092016 @default.
- W1998788809 countsByYear W19987888092021 @default.
- W1998788809 crossrefType "journal-article" @default.
- W1998788809 hasAuthorship W1998788809A5008053131 @default.
- W1998788809 hasAuthorship W1998788809A5009344154 @default.
- W1998788809 hasAuthorship W1998788809A5038071947 @default.
- W1998788809 hasAuthorship W1998788809A5044244232 @default.
- W1998788809 hasAuthorship W1998788809A5051391047 @default.
- W1998788809 hasAuthorship W1998788809A5070718117 @default.
- W1998788809 hasConcept C113842279 @default.
- W1998788809 hasConcept C147483822 @default.
- W1998788809 hasConcept C153911025 @default.
- W1998788809 hasConcept C159654299 @default.
- W1998788809 hasConcept C203014093 @default.
- W1998788809 hasConcept C2778461978 @default.
- W1998788809 hasConcept C2778913318 @default.
- W1998788809 hasConcept C2779282312 @default.
- W1998788809 hasConcept C2779338263 @default.
- W1998788809 hasConcept C502942594 @default.
- W1998788809 hasConcept C542903549 @default.
- W1998788809 hasConcept C54355233 @default.
- W1998788809 hasConcept C81885089 @default.
- W1998788809 hasConcept C86803240 @default.
- W1998788809 hasConceptScore W1998788809C113842279 @default.
- W1998788809 hasConceptScore W1998788809C147483822 @default.
- W1998788809 hasConceptScore W1998788809C153911025 @default.
- W1998788809 hasConceptScore W1998788809C159654299 @default.
- W1998788809 hasConceptScore W1998788809C203014093 @default.
- W1998788809 hasConceptScore W1998788809C2778461978 @default.
- W1998788809 hasConceptScore W1998788809C2778913318 @default.
- W1998788809 hasConceptScore W1998788809C2779282312 @default.
- W1998788809 hasConceptScore W1998788809C2779338263 @default.
- W1998788809 hasConceptScore W1998788809C502942594 @default.
- W1998788809 hasConceptScore W1998788809C542903549 @default.
- W1998788809 hasConceptScore W1998788809C54355233 @default.
- W1998788809 hasConceptScore W1998788809C81885089 @default.
- W1998788809 hasConceptScore W1998788809C86803240 @default.
- W1998788809 hasIssue "5" @default.
- W1998788809 hasLocation W19987888091 @default.
- W1998788809 hasLocation W19987888092 @default.
- W1998788809 hasOpenAccess W1998788809 @default.
- W1998788809 hasPrimaryLocation W19987888091 @default.
- W1998788809 hasRelatedWork W1943797027 @default.
- W1998788809 hasRelatedWork W1997716688 @default.
- W1998788809 hasRelatedWork W2013545418 @default.